Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2904
Selected: 0
NCT IDTitle
NCT04702880A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer
NCT00736879Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
NCT02109666Long Term Experience With Abatacept in Routine Clinical Practice
NCT05304533A Study to Assess the Drug Interaction Between MYK-224 and Itraconazole and Verapamil in Healthy Participants
NCT00634452Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma
NCT02912234Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants
NCT00080509Effectiveness of KOS-862 in the Treatment of Lung Cancer
NCT00861614Study of Immunotherapy to Treat Advanced Prostate Cancer
NCT00633789Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
NCT00730652Study of MDX-1411 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma
NCT01236235Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
NCT04766476A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease
NCT04698187CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
NCT00803647A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver
NCT04550247A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France
NCT03692325Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
NCT03465592Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
NCT00169819EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study
NCT05543629A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer
NCT02529072Nivolumab With DC Vaccines for Recurrent Brain Tumors
NCT03569436Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread
NCT00827411Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy
NCT02426892Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors
NCT03362411A Study to Assess the Absorption of a Single Dose of BMS-986205 in Healthy Volunteers When Administered as a Crushed Tablet Orally or Crushed Tablet Suspension Via Nasogastric Tube, as Compared to a Tablet
NCT02983045A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors
NCT06013995A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus
NCT01257412Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone
NCT03337919ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma
NCT05001087A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
NCT05064787Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
NCT03667716COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
NCT00734864Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
NCT05421299A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
NCT03141177A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
NCT00002358A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV
NCT03355976BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
NCT03245515A Study of BMS-986195 in Healthy Male Subjects
NCT02427126Apixaban for Treatment of Embolic Stroke of Undetermined Source
NCT04328298French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
NCT02186249Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
NCT03583008Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF
NCT04039607A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma
NCT00412984Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
NCT00826449Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
NCT01333878Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural Damage
NCT03568435Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants
NCT03711058Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
NCT00578448Belatacept Pharmacokinetic Trial in Renal Transplantation
NCT01413906Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors
NCT00355238A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer